How Can We Help You?


Quick Info:

Find a Doctor Specialties (800) 213-3284

Go To Home PageBack

Venous Thromboembolism - Cancer Related

Protocol Number: ACCRU-SC-1601

Protocol Title: A Phase III, Randomized, Controlled, Double-Blind Study Evaluating the Safety of Two Doses of Apixaban for Secondary Prevention of Cancer Related Venous Thrombosis in Subjects Who Have Completed at Least Six months of Anticoagulation Therapy

Eligibility: Women or Men ages 18 or older, with cancer and greater than 6 months but less than one year of anticoagulant therapy

Contact Information: (910) 715-2200


Select Clinical Trial

Venous Thromboembolism - Cancer Related

Clara McLean House
Make a Donation
News & Events